Rudolf Kwan - Apr 22, 2022 Form 4 Insider Report for Athenex, Inc. (ATNXQ)

Role
EVP, Chief Medical Officer
Signature
/s/ Steven Adams, Attorney-in-Fact
Stock symbol
ATNXQ
Transactions as of
Apr 22, 2022
Transactions value $
$4,900
Form type
4
Date filed
4/29/2022, 04:24 PM
Previous filing
Apr 11, 2022
Next filing
May 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATNXQ Common Stock Award $4.9K +7.99K +4.3% $0.61 194K Apr 22, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ATNXQ Stock Option (Right to Buy) 96K Apr 22, 2022 Common Stock 96K $4.55 Direct
holding ATNXQ Stock Option (Right to Buy) 48K Apr 22, 2022 Common Stock 48K $4.55 Direct
holding ATNXQ Stock Option (Right to Buy) 120K Apr 22, 2022 Common Stock 120K $4.55 Direct
holding ATNXQ Stock Option (Right to Buy) 48K Apr 22, 2022 Common Stock 48K $4.55 Direct
holding ATNXQ Stock Option (Right to Buy) 200K Apr 22, 2022 Common Stock 200K $5.50 Direct
holding ATNXQ Stock Option (Right to Buy) 120K Apr 22, 2022 Common Stock 120K $7.50 Direct
holding ATNXQ Stock Option (Right to Buy) 140K Apr 22, 2022 Common Stock 140K $11.00 Direct
holding ATNXQ Stock Option (Right to Buy) 120K Apr 22, 2022 Common Stock 120K $17.30 Direct
holding ATNXQ Stock Option (Right to Buy) 120K Apr 22, 2022 Common Stock 120K $13.17 Direct F2
holding ATNXQ Stock Option (Right to Buy) 140K Apr 22, 2022 Common Stock 140K $12.45 Direct F3
holding ATNXQ Stock Option (Right to Buy) 70K Apr 22, 2022 Common Stock 70K $3.80 Direct F4
holding ATNXQ Restricted Stock Units 70K Apr 22, 2022 Common Stock 70K Direct F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares purchased from the Issuer under a Salary Deduction and Stock Purchase Agreement at the Nasdaq Official Closing Price on the date of purchase.
F2 This option vests in four equal annual installments beginning on February 28, 2020.
F3 This option vests in four equal annual installments beginning on June 5, 2021.
F4 The option vests in four equal annual installments beginning on August 3, 2022.
F5 Each restricted stock unit represents a contingent right to receive one share of stock.
F6 The restricted stock units vest in four equal annual installments beginning on August 3, 2022.